Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002316620 | SCV000666741 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2018-11-08 | criteria provided, single submitter | clinical testing | The p.V174F variant (also known as c.520G>T), located in coding exon 5 of the NF1 gene, results from a G to T substitution at nucleotide position 520. The valine at codon 174 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis.Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
| Invitae | RCV000820168 | SCV000960868 | uncertain significance | Neurofibromatosis, type 1 | 2022-11-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NF1 protein function. ClinVar contains an entry for this variant (Variation ID: 481930). This variant has not been reported in the literature in individuals affected with NF1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 174 of the NF1 protein (p.Val174Phe). |
| Genome- |
RCV000820168 | SCV002561478 | uncertain significance | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
| Fulgent Genetics, |
RCV002483529 | SCV002775981 | uncertain significance | Neurofibromatosis, familial spinal; Juvenile myelomonocytic leukemia; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis | 2022-04-29 | criteria provided, single submitter | clinical testing | |
| Baylor Genetics | RCV003465204 | SCV004198378 | uncertain significance | Juvenile myelomonocytic leukemia | 2023-08-05 | criteria provided, single submitter | clinical testing |